Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development of LAG-3/FGL1 blocking peptide and combination with radiotherapy for cancer immunotherapy
Yuzhen Qian, Yixuan Sun, Peishang Shi, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 3, pp. 1150-1165
Open Access | Times Cited: 11

Showing 11 citing articles:

Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 16
Immunomodulatory Peptides for Tumor Treatment
Yang Song, Longtianyang Lei, Xingyu Cai, et al.
Advanced Healthcare Materials (2024)
Closed Access | Times Cited: 7
Prospects of Synergy: Local Interventions and CAR T Cell Therapy in Solid Tumors
Anne Holtermann, Mila Gislon, Martin K. Angele, et al.
BioDrugs (2024) Vol. 38, Iss. 5, pp. 611-637
Open Access | Times Cited: 4
Peptide‑based therapeutic strategies for glioma: current state and prospects
Yajing Mi, Pengtao Jiang, Jing Luan, et al.
Peptides (2025) Vol. 185, pp. 171354-171354
Closed Access
LAG3, TIM3 and TIGIT: New Targets for Immunotherapy and Potential Associations with Radiotherapy
Camil Ciprian Mireștean, Roxana Irina Iancu, Dragoș Petru Teodor Iancu
Current Oncology (2025) Vol. 32, Iss. 4, pp. 230-230
Open Access
Two Step Synthesis of Octreotide-doxorubicin Conjugates Based on Disulfide Bond Linker
Qian-Yao Yu, Ming Meng, Jing-Fang Yao, et al.
Acta Chimica Sinica (2025) Vol. 83, Iss. 4, pp. 341-341
Closed Access
A novel peptide targeting CCR7 inhibits tumor cell lymph node metastasis
Yixuan Sun, Yuzhen Qian, Lu Qiu, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 5
Open Access
Recent Advances in Augmenting the Therapeutic Efficacy of Peptide–Drug Conjugates
Jiahui Ma, Xuedan Wang, Yong-hua Hu, et al.
Journal of Medicinal Chemistry (2025)
Open Access
VISTA as a context-dependent immune checkpoint: Implications for tumor immunity and autoimmune pathogenesis
Xiaoshuang Niu, Beibei Li, Feng Luo, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025) Vol. 1880, Iss. 3, pp. 189351-189351
Closed Access
FGL1 and FGL2: emerging regulators of liver health and disease
Jiongming Chen, Lei Wu, Yongsheng Li
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 3
Deciphering Regulatory T-Cell Dynamics in Cancer Immunotherapy: Mechanisms, Implications, and Therapeutic Innovations
Sankha Bhattacharya, Gaurav Paraskar, Megha Jha, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 8, pp. 2215-2236
Closed Access | Times Cited: 2
FGL1 facilitates rather than suppresses anticancer immunity against microsatellite instable gastric cancer
Zhenyuan Qian, Xufan Cai, Jianzhang Wu, et al.
Genes and Immunity (2024)
Closed Access
Page 1

Scroll to top